glp-1 news today nov 2025 weight-loss drugs may soon get cheaper thanks to a new federal deal with major drugmakers. But what happens if you stop taking them? UVA EHD's Siddhartha Angadi, a cardiovascular exercise physiologist People who stop weight loss

Take photos and measurements, not just scale weight

In 2025, the GLP-1 Drug Market value stood at USD 37.57 Billion

Most professional organizations and regulatory bodies recommend against GLP-1 use during breastfeeding, not because of proven danger, but because of insufficient data to confirm safety definitively

A., Akter, N., Murata, Y

Given that fluoropyrimidine-based therapy will remain a major treatment modality for patients with advanced CRC for the foreseeable future, the need for better, more effective chemotherapy combinations in biologically selected populations to overcome drug resistance is an urgent, unmet need for patients with CRC worldwide

In animal studies SGLT2 inhibitors were excreted in breast milk and affected neonatal growth, but human data are not available